BioSpace News Archive

The first U.S. heart patient involved in a study for a new gene-editing therapy directly infused inside the body has successfully been enrolled at MedStar Washington Hospital Center.

Establishment Labs Holdings Inc. noted the presentation today of an update on the Motiva US IDE Study.

Ora, Inc., the foremost global ophthalmology contract research organization, announced a strategic, exclusive partnership with the Singapore Eye Research Institute, a world-renowned institution for cutting-edge eye research and ophthalmic preclinical studies.

Kriya Therapeutics, Inc. announced three presentations at the Association for Research in Vision and Ophthalmology Annual Meeting, which will be held May 5 to 9, 2024 in Seattle, WA.

ASLAN Pharmaceuticals announced that it has signed a new research collaboration agreement with its partner, Zenyaku Kogyo Co., Ltd., to establish a framework for a succession of research projects to explore the differentiation of eblasakimab’s mechanism of action versus biologic therapies for atopic dermatitis, dupilumab and lebrikizumab.